Patients receiving treatment from a primary care physician do not always receive the recommended medications to prevent a heart attack. Women found less likely to receive cholesterol-lowering drugs, aspirin, yet equally likely to receive the blood-pressure-lowering drug.
While there are differences between how women and men display in heart attack symptoms, researchers argue that continuing to simplify these symptoms as ‘typical’ or ‘atypical’ could contribute to delayed treatment and poorer health outcomes.
$53 million cash injection from Australian investors - one of the country’s largest-ever private-public health partnerships.
Funds set to accelerate research and development by George Health and George Medicines – companies established by one of the world’s leading medical research institutes.